QuantRx Biomedical Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QTXB research report →
Company
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs.
- CEO
- Shalom Z. Hirschman
- IPO
- 2004
- HQ
- Tualatin, OR, US
Price Chart
Valuation
- Market Cap
- $118.05K
- P/E
- -0.08
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 18.98%
- ROIC
- 1016.23%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-476,701 · -1.54%
- EPS
- $-0.01 · -1.67%
- Op Income
- $-43,383
- FCF YoY
- 33.96%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -2.04
- Avg Volume
- 24.98K
Get TickerSpark's AI analysis on QTXB
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 25, 12 | Hirschman Shalom | other | 150,000 |
| May 25, 12 | FLEMING WILLIAM H | other | 300,000 |
| Mar 1, 12 | ABRAMS MICHAEL S | other | 0 |
| Apr 30, 10 | PINCO ROBERT G. | other | 0 |
| Apr 30, 10 | MOONEY PATRICK T | other | 0 |
| Nov 15, 08 | MOONEY PATRICK T | other | 1,250 |
| Dec 31, 09 | HAYES ARTHUR H JR | other | 12,500 |
| Dec 31, 09 | Hirschman Shalom | other | 12,500 |
| Jul 30, 09 | FLEMING WILLIAM H | other | 125,000 |
| Jul 24, 09 | FLEMING WILLIAM H | other | 150,000 |
Our QTXB Coverage
We haven't published any research on QTXB yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QTXB Report →